Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
- PMID: 16369537
- DOI: 10.1038/ni1281
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
Abstract
Despite limited data supporting the superiority of dominant over subdominant responses, immunodominant epitopes represent the preferred vaccine candidates. To address the function of subdominant responses in human immunodeficiency virus infection, we analyzed cytotoxic T lymphocyte responses restricted by HLA-B*1503, a rare allele in a cohort infected with clade B, although common in one infected with clade C. HLA-B*1503 was associated with reduced viral loads in the clade B cohort but not the clade C cohort, although both shared the immunodominant response. Clade B viral control was associated with responses to several subdominant cytotoxic T lymphocyte epitopes, whereas their clade C variants were less well recognized. These data suggest that subdominant responses can contribute to in vivo viral control and that high HLA allele frequencies may drive the elimination of subdominant yet effective epitopes from circulating viral populations.
Comment in
-
Crosscurrents in HIV-1 evolution.Nat Immunol. 2006 Feb;7(2):121-2. doi: 10.1038/ni0206-121. Nat Immunol. 2006. PMID: 16424885 No abstract available.
Similar articles
-
Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.J Gen Virol. 1998 Sep;79 ( Pt 9):2191-201. doi: 10.1099/0022-1317-79-9-2191. J Gen Virol. 1998. PMID: 9747728
-
Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.J Virol. 2015 May;89(10):5330-9. doi: 10.1128/JVI.00020-15. Epub 2015 Mar 4. J Virol. 2015. PMID: 25741000 Free PMC article.
-
The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.J Virol. 2005 Apr;79(8):5000-5. doi: 10.1128/JVI.79.8.5000-5005.2005. J Virol. 2005. PMID: 15795285 Free PMC article.
-
Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1433-43. doi: 10.1089/08892220050140982. AIDS Res Hum Retroviruses. 2000. PMID: 11018863 Review.
-
Escape of human immunodeficiency virus from immune control.Annu Rev Immunol. 1997;15:271-96. doi: 10.1146/annurev.immunol.15.1.271. Annu Rev Immunol. 1997. PMID: 9143689 Review.
Cited by
-
Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens.Mol Immunol. 2013 Nov;56(1-2):81-90. doi: 10.1016/j.molimm.2013.04.011. Epub 2013 May 18. Mol Immunol. 2013. PMID: 23688437 Free PMC article.
-
Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine.PLoS Negl Trop Dis. 2020 Sep 21;14(9):e0008676. doi: 10.1371/journal.pntd.0008676. eCollection 2020 Sep. PLoS Negl Trop Dis. 2020. PMID: 32956362 Free PMC article.
-
High frequency of CD8 escape mutations in elite controllers as new obstacle for HIV cure.Virulence. 2022 Dec;13(1):1713-1719. doi: 10.1080/21505594.2022.2129353. Virulence. 2022. PMID: 36190143 Free PMC article.
-
Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication.J Virol. 2007 Apr;81(7):3465-76. doi: 10.1128/JVI.02392-06. Epub 2007 Jan 24. J Virol. 2007. PMID: 17251286 Free PMC article.
-
The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease.Viral Immunol. 2020 Apr;33(3):160-178. doi: 10.1089/vim.2019.0184. Viral Immunol. 2020. PMID: 32286182 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials